ScholarX

Browsing by Kato, T[Kato, Terufumi]Author

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 6 of 6

SCIESCOPUS
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trialsopen access

Wu, YL[Wu, Yi-Long]; Sequist, LV[Sequist, Lecia V.]; Tan, EH[Tan, Eng-Huat]; Geater, SL[Geater, Sarayut L.]; Orlov, S[Orlov, Sergey]; Zhang, L[Zhang, Li]; Lee, KH[Lee, Ki Hyeong]; Tsai, CM[Tsai, Chun-Ming]; Kato, T[Kato, Terufumi]; Barrios, CH[Barrios, Carlos H.], et al.

ArticleIssue Date2018CitationCLINICAL LUNG CANCER, v.19, no.4, pp.E465 - E479PublisherCIG MEDIA GROUP, LP
SCIESCOPUS
KEYNOTE-671: Randomized, double-blind, phase 3 study of pembrolizumab or placebo plus platinum-based chemotherapy followed by resection and pembrolizumab or placebo for early stage NSCLC.

Wakelee, HA[Wakelee, Heather A.]; Liberman, M[Liberman, Moishe]; Kato, T[Kato, Terufumi]; Tsuboi, M[Tsuboi, Masahiro]; Lee, SH[Lee, Se-Hoon]; He, J[He, Jie]; Gao, SG[Gao, Shugeng]; Chen, KN[Chen, Ke-Neng]; Dooms, CA[Dooms, Christophe Alfons]; Majem, M[Majem, Margarita], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.17PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer

Wakelee, H[Wakelee, Heather]; Liberman, M[Liberman, Moishe]; Kato, T[Kato, Terufumi]; Tsuboi, M[Tsuboi, Masahiro]; Lee, SH[Lee, Se-Hoon]; Gao, SG[Gao, Shugeng]; Chen, KN[Chen, Ke-Neng]; Dooms, C[Dooms, Christophe]; Majem, M[Majem, Margarita]; Eigendorff, E[Eigendorff, Ekkehard], et al.

ArticleIssue Date2023CitationNEW ENGLAND JOURNAL OF MEDICINE, v.389, no.6, pp.491 - 503PublisherMASSACHUSETTS MEDICAL SOC
SCIESCOPUS
Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer

Kubota, K[Kubota, Kaoru]; Yoshioka, H[Yoshioka, Hiroshige]; Oshita, F[Oshita, Fumihiro]; Hida, T[Hida, Toyoaki]; Yoh, K[Yoh, Kiyotaka]; Hayashi, H[Hayashi, Hidetoshi]; Kato, T[Kato, Terufumi]; Kaneda, H[Kaneda, Hiroyasu]; Yamada, K[Yamada, Kazuhiko]; Tanaka, H[Tanaka, Hiroshi], et al.

ArticleIssue Date2017CitationJOURNAL OF CLINICAL ONCOLOGY, v.35, no.32, pp.3662 - +PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
PRELIMINARY SAFETY RESULTS OF MONET-A: A PROSPECTIVE, ASIAN PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF THE INVESTIGATIONAL AGENT MOTESANIB IN COMBINATION WITH PACLITAXEL AND CARBOPLATIN FOR ASIAN PATIENTS OF ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER

Yoshioka, H[Yoshioka, Hiroshige]; Oshita, F[Oshita, Fumihiro]; Nogami, N[Nogami, Naoyuki]; Kaneda, H[Kaneda, Hiroyasu]; Yoh, K[Yoh, Kiyotaka]; Kato, T[Kato, Terufumi]; Cho, BC[Cho, Byoung Chul]; Chang, GC[Chang, Gee-Chen]; Ichinose, Y[Ichinose, Yukito]; Nakagawa, K[Nakagawa, Kazuhiko], et al.

ArticleIssue Date2013CitationJOURNAL OF THORACIC ONCOLOGY, v.8, pp.S1186 - S1186
SCIESCOPUS
Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping.

Kato, T[Kato, Terufumi]; Yang, JCH[Yang, James Chih-Hsin]; Ahn, MJ[Ahn, Myung-Ju]; Sakai, H[Sakai, Hiroshi]; Morise, M[Morise, Masahiro]; Chen, YM[Chen, Yuh-Min]; Han, JY[Han, Ji-Youn]; Yang, JJ[Yang, Jin-Ji]; Zhao, J[Zhao, Jun]; Huang, J[Huang, Jason], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
1
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어